JP2018511648A5 - - Google Patents

Download PDF

Info

Publication number
JP2018511648A5
JP2018511648A5 JP2017555866A JP2017555866A JP2018511648A5 JP 2018511648 A5 JP2018511648 A5 JP 2018511648A5 JP 2017555866 A JP2017555866 A JP 2017555866A JP 2017555866 A JP2017555866 A JP 2017555866A JP 2018511648 A5 JP2018511648 A5 JP 2018511648A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
acceptable salt
compound
alkyl
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017555866A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018511648A (ja
JP6723264B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2016/050276 external-priority patent/WO2016116875A1/en
Publication of JP2018511648A publication Critical patent/JP2018511648A/ja
Publication of JP2018511648A5 publication Critical patent/JP2018511648A5/ja
Application granted granted Critical
Publication of JP6723264B2 publication Critical patent/JP6723264B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017555866A 2015-01-20 2016-01-20 Petイメージング剤 Expired - Fee Related JP6723264B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562105336P 2015-01-20 2015-01-20
US62/105,336 2015-01-20
PCT/IB2016/050276 WO2016116875A1 (en) 2015-01-20 2016-01-20 Pet imaging agents

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020106739A Division JP2020158532A (ja) 2015-01-20 2020-06-22 Petイメージング剤

Publications (3)

Publication Number Publication Date
JP2018511648A JP2018511648A (ja) 2018-04-26
JP2018511648A5 true JP2018511648A5 (cg-RX-API-DMAC10.html) 2019-02-21
JP6723264B2 JP6723264B2 (ja) 2020-07-15

Family

ID=55300733

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017555866A Expired - Fee Related JP6723264B2 (ja) 2015-01-20 2016-01-20 Petイメージング剤
JP2020106739A Pending JP2020158532A (ja) 2015-01-20 2020-06-22 Petイメージング剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020106739A Pending JP2020158532A (ja) 2015-01-20 2020-06-22 Petイメージング剤

Country Status (12)

Country Link
US (2) US10450298B2 (cg-RX-API-DMAC10.html)
EP (1) EP3247706B1 (cg-RX-API-DMAC10.html)
JP (2) JP6723264B2 (cg-RX-API-DMAC10.html)
KR (1) KR20170103960A (cg-RX-API-DMAC10.html)
CN (1) CN107406419B (cg-RX-API-DMAC10.html)
AU (1) AU2016209906A1 (cg-RX-API-DMAC10.html)
BR (1) BR112017015455A2 (cg-RX-API-DMAC10.html)
CA (1) CA2974311A1 (cg-RX-API-DMAC10.html)
EA (1) EA201791643A1 (cg-RX-API-DMAC10.html)
ES (1) ES2828715T3 (cg-RX-API-DMAC10.html)
MX (1) MX2017009452A (cg-RX-API-DMAC10.html)
WO (1) WO2016116875A1 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170103960A (ko) 2015-01-20 2017-09-13 노파르티스 아게 Pet 영상화제
TWI809597B (zh) * 2020-12-16 2023-07-21 美商美國禮來大藥廠 預靶向造影劑

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0224917D0 (en) * 2002-10-25 2002-12-04 Novartis Ag Organic compounds
WO2005043300A2 (en) 2003-10-20 2005-05-12 Empirix, Inc. Computer language interpretation and optimization for server testing
EP1740565A2 (en) 2004-04-28 2007-01-10 ICOS Corporation Arylphenylamino-, arylphenylamide-, and arylphenylether-sufide derivatives
WO2005121094A1 (en) 2004-06-09 2005-12-22 Pfizer Limited Piperazine and piperidine derivatives as anti-hiv-agents
CN101429161A (zh) * 2008-12-05 2009-05-13 常熟理工学院 Pet显像剂前体异喹啉甲酰胺衍生物的合成方法
JP5767205B2 (ja) * 2009-04-02 2015-08-19 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung オートタキシン阻害剤としての複素環式化合物
WO2012020567A1 (en) 2010-08-09 2012-02-16 Raqualia Pharma Inc. Acyl piperazine derivatives as ttx-s blockers
EP2606031B1 (en) * 2010-08-20 2017-09-27 Amira Pharmaceuticals, Inc. Autotaxin inhibitors and uses thereof
SI2861566T1 (sl) * 2012-06-13 2017-03-31 F. Hoffmann-La Roche Ag Novi diazaspirocikloalkan in azaspirocikloalkan
EP2935249B1 (en) 2012-12-19 2018-12-12 Novartis AG Autotaxin inhibitors
PT3022202T (pt) * 2013-07-18 2019-09-03 Novartis Ag Inibidores da autotaxina compreendendo um núcleo beteroaromático anel-benzilo-amida-ciclo
KR20170103960A (ko) 2015-01-20 2017-09-13 노파르티스 아게 Pet 영상화제

Similar Documents

Publication Publication Date Title
RU2324686C2 (ru) ПРОИЗВОДНЫЕ ТИОФЛАВИНА, СВЯЗЫВАЮЩИЕ АМИЛОИД, СПОСОБ ОБНАРУЖЕНИЯ in vivo ОТЛОЖЕНИЙ АМИЛОИДА И СПОСОБ РАСПОЗНАВАНИЯ БОЛЕЗНИ АЛЬЦГЕЙМЕРА
US8435489B2 (en) Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma
JP2012102106A5 (cg-RX-API-DMAC10.html)
JP2017521387A5 (cg-RX-API-DMAC10.html)
Sanad et al. Comparative biological evaluation between 99mTc (CO) 3 and 99mTc-Sn (II) complexes of novel quinoline derivative: a promising infection radiotracer
JP2010523599A5 (cg-RX-API-DMAC10.html)
JP2010514786A5 (cg-RX-API-DMAC10.html)
JP2010529088A5 (cg-RX-API-DMAC10.html)
JP2018532689A5 (cg-RX-API-DMAC10.html)
JP2010535210A5 (cg-RX-API-DMAC10.html)
JP2010524857A5 (cg-RX-API-DMAC10.html)
JP2010524965A5 (cg-RX-API-DMAC10.html)
JP2016505582A5 (cg-RX-API-DMAC10.html)
JP2016528299A5 (cg-RX-API-DMAC10.html)
RU2005131872A (ru) Производные бензотиазола (варианты), фармацевтическая композиция для детекции отложений амилоида и способ их детекции у млекопитающего
RU2008147002A (ru) Новые соединения, обладающие сродством к амилоиду
JP2018520124A5 (cg-RX-API-DMAC10.html)
JP2012504581A5 (cg-RX-API-DMAC10.html)
JP2009538894A5 (cg-RX-API-DMAC10.html)
JP2013507345A5 (cg-RX-API-DMAC10.html)
US20100228012A1 (en) Pendant fatty acid imaging agents
US12533428B2 (en) Multimodal fluorine-CY3/5/7-DOTA-hapten compositions, diagnostics, fluorescence guided surgery and radioimmunotherapy
Passannante et al. Pharmacokinetic evaluation of new drugs using a multi-labelling approach and pet imaging: application to a drug candidate with potential application in neuromuscular disorders
JP2017206457A (ja) 肝臓及び/又は腎臓機能の診断剤
JP2019001761A (ja) 腫瘍イメージング剤、及びホウ素中性子捕捉療法用腫瘍治療剤